XWPharma
is a biotechnology company that develops and commercializes novel therapeutics for the treatment of neurodegenerative diseases... Read moreXWPharma
is a biotechnology company that develops and commercializes novel therapeutics for the treatment of neurodegenerative diseases... Read more
News
Oct 19, 2021
Business News Asia
XWPharma: Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Sep 08, 2021
GlobalNewswire
Press Release: XWPharma : XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Jun 14, 2021
GlobalNewswire
Press Release: XWPharma : XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172, in Development as Once-Nightly Therapy for Sleep Disorders in Patients with Neurodegenerative Diseases
May 19, 2021
Benzinga
XWPharma: XWPharma Announces Abstract for XW10172 Accepted for Presentation at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting
Dec 16, 2020
Benzinga
XWPharma: XWPharma Names Michael M. Morrissey, PhD to Board of Directors
Sep 18, 2020
Asian Venture Capital Journal
XWPharma: Panacea leads $40m Series C for China's XWPharma
Sep 18, 2020
China Money Network
XWPharma: Chinese Biotech Startup XW Laboratories Completes $40M Round
Sep 17, 2020
BioSpace
XWPharma: XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer
Sep 17, 2020
ChinaBio Today
XWPharma: XWPharma Completes $40 Million Round for Neurobiology Candidates
XWPharma Competitors
1
2
3
4
5
6
7
8
9
10